冠心病心绞痛患者PCI围手术期CRP、Lp（a）水平检测及其与心肌损伤的相关性

Abstract
Figure/Table
References (27)
Related Citation (15)

Download: PDF (349 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To observe the levels of C-reactive protein (CRP) and lipoprotein (a) [Lp(a)] in the percutaneous coronary intervention (PCI) perioperative period in patients with coronary heart disease and angina pectoris and their correlation with myocardial injury. Methods The clinical data of 80 patients with coronary heart disease and angina pectoris diagnosed and treated in Chaozhou Central Hospital in Guangdong Province (“our hospital” for short) from March 2020 to March 2021 were retrospectively analyzed. According to the type of angina pectoris, they were divided into stable group (stable angina pectoris, 38 cases), and unstable group (unstable angina, 42 cases). In addition, 50 healthy people who received physical examination in our hospital during the same period were selected as the control group. The immunoscattering turbidimetric method was used to detect the CRP level, the cardiac marker detector was used to detect the cardiac troponin T (cTnT) level, and the Beckman DXC600 detector was used to detect the Lp(a) level. According to the postoperative value of cTnT, they were divided into normal group (cTnT＜0.014 μg/L, 32 cases) and elevated group (cTnT＞0.014 μg/L, 48 cases), and the levels of CRP and Lp(a) were compared between the two groups. At the same time, multivariate logistic regression was selected to analyze the correlation between CRP, Lp(a) levels and myocardial injury. Results The CRP and Lp(a) levels of the stable group and the unstable group were higher than those of the control group, while the unstable group was higher than the stable group, and the differences were statistically significant (P ＜ 0.05). The levels of CRP and Lp(a) in the elevated group were higher than those in the normal group, and the differences were statistically significant (P ＜ 0.05). High levels of CRP and Lp(a) were independent risk factors for the increase of cTnT in patients with coronary heart disease and angina pectoris during PCI perioperative period (OR ＞ 1, P ＜ 0.05). Conclusion The levels of CRP and Lp(a) in patients with coronary heart disease and angina pectoris increased significantly during PCI perioperative period, and the increased levels of CRP and Lp(a) are independent risk factors for myocardial injury after PCI.

Key words： Coronary heart disease Angina pectoris Myocardial injury Percutaneous coronary intervention C-reactive protein Lipoprotein(a) Correlation

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHAN Yongzhong1 XU Xianbin1 HUANG Zewei2

Cite this article:

ZHAN Yongzhong1 XU Xianbin1 HUANG Zewei2. Detection of CRP and Lp(a) levels and correlation with myocardial injury during PCI perioperative period in patients with coronary heart disease and angina pectoris #br#[J]. 中国医药导报, 2021, 18(35): 76-79.

URL:

https://www.yiyaodaobao.com.cn/EN/ OR https://www.yiyaodaobao.com.cn/EN/Y2021/V18/I35/76

[1] 赵凯，高晟，李永健，等.红细胞分布宽度对冠心病心绞痛患者行冠状动脉介入治疗术后发生对比剂肾病的影响研究[J].中国全科医学，2018，21（1）：67-71.
[2] Heusch G，Gersh BJ. The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion：a continual challenge [J]. Eur Heart J，2017， 38（11）：774-784.
[3] Ahmed LA. Nicorandil：A drug with ongoing benefits and different mechanisms in various diseased conditions [J]. Indian J Pharmacol，2019，51（5）：296-301.
[4] 刘红旭，吴永健，王显，等.经皮冠状动脉介入治疗围手术期心肌损伤中医诊疗专家共识[J].中国中西医结合杂志，2017，37（4）：389-393.
[5] Shiga T，Hiraide M. Cardiotoxicities of 5-Fluorouracil and Other Fluoropyrimidines [J]. Curr Treat Options Oncol，2020， 21（4）：27.
[6] 林勇军，吴春芳，叶志荣，等.超敏C反应蛋白和脑钠肽及脂联素水平与冠心病患者相关性[J].中国临床药理学杂志，2017，33（5）：463-466.
[7] 李红艳.冠心病患者PCSK9和脂蛋白（a）水平与冠状动脉病变程度的相关性[J].中国动脉硬化杂志，2016，24（6）：607-610.
[8] 姬尚义，沈宗林.缺血性心脏病[M].北京：人民卫生出版社，2005：198-205.
[9] Pothineni NVK，Subramany S，Kuriakose K，et al. Infections，atherosclerosis，and coronary heart disease [J]. Eur Heart J，2017，38（43）：3195-3201.
[10] 张洪兵，李七一.冠心平片对冠心病心绞痛患者抗氧化酶及炎症因子的影响[J].中成药，2017，39（7）：1545-1547.
[11] 朱艳霞，李素云，王竹文，等.不稳定型心绞痛合并2型糖尿病患者PTX3水平及其与载脂蛋白A1/载脂蛋白B的相关性[J].中国老年学杂志，2016，36（17）：4210-4211.
[12] 郭旗，马维冬，张春艳，等.冠心病患者血浆hs-CRP、IL-6和可溶性IL-6受体水平的变化及意义[J].西安交通大学学报：医学版，2016，37（3）：349-352.
[13] 庞高峰，徐敏，龚明霞，等.左室心肌整体纵向应变与CRP及ESR评估川崎病急性期患儿心肌损伤的研究[J].临床儿科杂志，2018，36（10）：748-751.
[14] 毛亮，张威，刘光辉，等.眼针疗法治疗冠心病心绞痛的疗效及对血CRP、TNF-α的影响[J].中华中医药学刊，2020，38（9）：30-33.
[15] 姬劲锐，刘静，刘恒亮，等.2型糖尿病合并冠心病患者血清炎性标志物变化与冠状动脉病变的相关性[J].山东医药，2017，57（33）：70-72.
[16] 孙俊翔，陈燕春，殷云杰，等.脂蛋白（a）与稳定型心绞痛患者经皮冠状动脉介入治疗围术期心肌损伤研究[J].介入放射学杂志，2019，28（1）：19-22.
[17] 马煜盛，饶甲环，龙洁旎，等.脂蛋白（a）与冠心病患者临床稳定性及冠状动脉狭窄程度的关系[J].南方医科大学学报，2019，39（2）：235-240.
[18] 黎洁雯，龙洁旎，李明星，等.脂蛋白（a）水平对冠心病患者药物洗脱支架植入术后支架内再狭窄及非靶病变的影响[J].解放军医学杂志，2019，44（10）：851-856.
[19] 牛川，王清.瑞舒伐他汀对不稳定型心绞痛患者血清Lp-PLA2、Lp（a）水平的影响[J].山东医药，2015，55（17）：61-62.
[20] 唐慧芸，王烨，姜盈缨，等.脂蛋白（a）与稳定性冠心病的关系及他汀类药物对其水平的影响研究[J].中国全科医学，2016，19（6）：666-671.
[21] 孙立峰，郭华，李亮，等.红花黄色素联合还原型谷胱甘肽对冠心病心肌梗死心功能、心肌损伤标志物的影响[J].中国老年学杂志，2020，40（4）：688-691.
[22] 陈燕春，殷云杰，徐亮，等.脂蛋白相关磷脂酶A2预测稳定型心绞痛患者经皮冠状动脉介入治疗围手术期心肌损伤研究[J].介入放射学杂志，2017，26（12）：1073-1077.
[23] 郭庆，成鑫，严洁婷，等.血清CysC、hs-CRP、Lp（a）在急性冠脉综合征患者中的表达及临床意义[J].中国医药导报，2019，16（2）：54-58.
[24] 徐国旺.冠状动脉介入治疗冠心病急性心肌梗死的临床疗效及其对心室重构的影响[J].中国医药科学，2021， 11（1）：225-228.
[25] 关婧，涂清鲜.择期经皮冠状动脉介入术治疗对急性心肌梗死患者左心室功能及心肌损伤相关指标的影响[J].中国老年学杂志，2018，38（23）：5639-5641.
[26] Razani Z，Dastani M，Kazerani HR. Cardioprotective Effects of Pomegranate （Punica granatum） Juice in Patients with Ischemic Heart Disease [J]. Phytother Res，2017，31（11）：1731-1738.
[27] Guler E，Guler GB，Kizilirmak F，et al. Evaluation of adiponectin and lipoprotein（a） levels in cardiac syndrome X [J]. Herz，2015，40（3）：291-297.